Back |
home / stock / konef / konef message board
Subject | By | Source | When |
---|---|---|---|
$KONEF Ketamine One Provides Second Update on Management | AskMuncher | investorshub | 11/29/2021 2:18:44 PM |
I've been on the Bid to Buy some | ListenToMe | investorshub | 11/25/2021 12:21:26 PM |
$KONEF Ketamine One Provides Update on Management Cease | AskMuncher | investorshub | 11/18/2021 10:20:23 AM |
$KONEF = .37 | ListenToMe | investorshub | 11/13/2021 3:04:56 PM |
I believe in 2022 will get $KONEF uplisting | ListenToMe | investorshub | 11/13/2021 12:36:47 PM |
I'm the ONLY follower here?? wow! | ListenToMe | investorshub | 11/13/2021 12:35:07 PM |
Still waiting for my fill please. | ListenToMe | investorshub | 11/11/2021 11:16:06 PM |
FILL MY ORDER PLEASE.... MM. Thanks | ListenToMe | investorshub | 10/26/2021 4:25:20 PM |
$KONEF Ketamine One Engages Psychology & Counselling Services | AskMuncher | investorshub | 09/15/2021 5:51:11 AM |
$KONEF Ketamine One Signs LOI for Two Ketamine | AskMuncher | investorshub | 09/12/2021 2:35:50 AM |
LET'S TALK! A sit down in the PSYCHEDELICS | StockHighAlert- | investorshub | 08/11/2021 7:29:06 PM |
$KONEF is pleased to announce it has signed | StockHighAlert- | investorshub | 08/05/2021 5:39:57 PM |
News, Short Squeeze, Breakout and More Instantly...
KetamineOne Capital Limited Company Name:
KONEF Stock Symbol:
OTCMKTS Market:
Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedel...
Wellbeing Digital Sciences Inc. (“ Wellbeing ” or the “ Company ”) ( NEO: MEDI ) ( OTC: KONEF ) ( FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psych...
Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedel...